Drugs and Biotech

Home: Sample Business Contracts: By Industry: Drugs and Biotech

aaiPharma Inc.

• 2000 Stock Option Plan for Non-Employee Directors - Applied Analytical Industries Inc. (2000)
• Asset Purchase Agreement - AstraZeneca AB and NeoSan Pharmaceuticals Inc. (Jul 25, 2001)
• Asset Purchase Agreement [Amendment No. 1] - AstraZeneca AB and aaiPharma LLC (Jul 22, 2003)
• Development Agreement - Applied Analytical Industries Inc. and Aesgen Inc. (Apr 4, 1995)
• Development Agreement - Applied Analytical Industries Inc. and GenerEst inc. (Apr 25, 1994)
• Employment Agreement - Applied Analytical Industries Inc. and Frederick D. Sancilio (Nov 17, 1995)
• Employment Agreement - aaiPharma Inc. and Frederick D. Sancilio (Jan 1, 2003)
• Exclusive Option Agreement - Applied Analytical Industries Inc. (May 28, 1996)
• Interim Supply Agreement [Amendment No. 1] - AstraZeneca LP and aaiPharma LLC (Jul 22, 2003)
• Loan Agreement - Applied Analytical Industries Inc. and NationsBank NA (Dec 30, 1996)
• Loan Agreement - Applied Analytical Industries Inc. and NationsBank of North Carolina NA (Dec 21, 1992)
• Loan Agreement - Applied Analytical Industries Inc., AAI Applied Analytical Industries Deutschland GmbH & Co. KG and Bank of America NA (Nov 30, 1999)
• NC-Durham-6110 Quadrangle Drive Lease - I-40 Properties and Applied Analytical Industries Inc. (Dec 23, 1993)
• NC-Wilmington-5051 New Centre Drive Lease - 5051 New Centre Drive LLC and Applied Analytical Industries Inc. (Mar 7, 1994)
• Pledge Agreement - Applied Analytical Industries Inc. and Bank of America NA (Aug 26, 1999)
• Product Sales Agreement - Aesgen Inc. and aaiPharma inc. (Dec 21, 2001)
• Securities Payment Agreement - AAI International Inc., aaiPharma Inc. and Endeavor Pharmaceuticals Inc. (Mar 25, 2003)
• Security Agreement - Applied Analytical Industries Inc. and Bank of America NA (Aug 26, 1999)
• Subscription Agreement - Aesgen Inc. and aaiPharma Inc. (Oct 19, 2001)

ABAXIS Inc.

• Distribution Agreement - MELET SCHLOESING Laboratoires and ABAXIS Inc. (Mar 11, 1999)
• Distribution Agreement - Scil Animal Care Co. GmbH and ABAXIS Inc. (Sep 1, 2001)
• Employee Retention Incentive Agreement - ABAXIS Inc. and Alberto Santa Ines (Apr 13, 2001)
• Employment Agreement - ABAXIS Inc. and Clint Severson (Jul 11, 2005)
• Employment Agreement - ABAXIS Inc. and Clinton H. Severson (Mar 31, 1997)
• Joint Representation Agreement - ABAXIS Inc. and SA Scientific Inc. (May 8, 2002)
• License Agreement - ABAXIS INc. and Pharmacia Biotech (Jun 9, 1997)
• Non-Exclusive Distributor Agreement - Henry Schein and ABAXIS Inc. (Apr 5, 2004)
• Private Label Manufacturing and Supply Agreement - Diatron Messtechnik GmbH and ABAXIS Inc. (Nov 13, 2003)

Abbott Laboratories

• Co-Promotion Agreement - Abbott Laboratories Inc. and Sepracor Inc. (Nov 19, 1999)
• Co-Promotion Agreement - Abbott Laboratories and MedImmune Inc. (Nov 26, 1997)
• Co-Promotion Agreement [Amendment No. 1] - Abbott Laboratories and MedImmune Inc. (Jul 31, 2000)
• Co-Promotion Agreement [Amendment No. 2] - Abbott Laboratories and MedImmune Inc. (Nov 29, 2001)
• Development and Supply Agreement - Cubist Pharmaceuticals Inc. and Abbott Laboratories (Apr 3, 2000)
• Distribution Agreement - MedImmune Inc. and Abbott International Ltd. (Nov 26, 1997)
• Distribution Agreement [Amendment No. 1] - MedImmune Inc. and Abbott International Ltd. (Apr 28, 1999)
• Distribution Agreement [Amendment No. 2] - MedImmune Inc. and Abbott International Ltd. (Oct 8, 1999)
• Distribution Agreement [Amendment No. 3] - MedImmune Inc. and Abbott International Ltd. (Jul 1, 2003)
• License Agreement - Abbott Laboratories and DrugAbuse Sciences Inc. (Aug 16, 2000)

Adolor Corp.

• License Agreement - Adolor Corp. and EpiCept Corp. (Jul 23, 2003)
• License Agreement [Amendment No. 1] - Adolor Corp. and EpiCept Corp. (Oct 1, 2004)

ADVENTRX Pharmaceuticals Inc.

• CA-San Diego-6725 Mesa Ridge Road Lease - Casey Family Trust and ADVENTRX Pharmaceuticals Inc. (Jun 3, 2004)
• Employee Leasing Contract - Biokeys Pharmaceuticals Inc. and Steven M. Plumb, P.C. (Jan 20, 2003)
• Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Brian M. Culley (Nov 15, 2004)
• Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Carrie E. Carlander (Nov 17, 2004)
• Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Cellia Habita (Mar 1, 2004)
• Employment Agreement - Biokeys Pharmaceuticals Inc. and Joan M. Robbins (Mar 5, 2003)
• Executive Employment Agreement - BioQuest Inc. and Warren C. Lau (Dec 1, 1999)
• License Agreement [Amendment No. 1] - University of Southern California and BioKeys Inc. (Jan 23, 1998)
• Option & License Agreement - University of Southern California and BioKeys Inc. (Aug 17, 2000)
• Option and License Agreement - University of Southern California and Biokeys Inc. (Jan 20, 1998)
• Option and License Agreement [Amendment] - University of Southern California and BioKeys Pharmaceuticals Inc. (Apr 21, 2003)
• Patent and Technology License Agreement - University of Texas, the University of Texas M. D. Anderson Cancer Center and BioQuest Inc. (Jun 14, 1996)
• Patent and Technology License Agreement [Amendment No. 1] - University of Texas, the University of Texas M. D. Anderson Cancer Center and BioKeys Pharameuticals Inc. (Jun 15, 2000)

Affymax Inc.

• Technology Transfer Agreement - Affymax Technologies NV, Glaxo Group Ltd. and Maxygen Inc. (Feb 1, 1997)

Agouron Pharmaceuticals Inc.

• Common Stock Purchase Agreement - Immune Response Corp. and Agouron Pharmaceuticals Inc. (Jun 11, 1998)
• Letter of Intent - Agouron Pharmaceuticals Inc. and Immune Response Corp. (Jun 11, 1998)

Albany Molecular Research Inc.

• Agreement - Albany Molecular Research Inc. and Cubist Pharmaceuticals Inc. (Jul 30, 2001)

Alkermes Inc.

• Change in Control Employment Agreement - Alkermes Inc. and Richard F. Pops (Dec 19, 2000)
• Development Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica International (Dec 23, 1993)
• Development Agreement [Amendment No. 1] - Medisorb Technologies International LP and Janssen Pharmaceutica International (Dec 23, 1993)
• Development Agreement [Amendment No. 2] - Janssen Pharmaceutica International, Medisorb Technologies International and Alkermes Controlled Therapeutics Inc. II (Mar 8, 1996)
• Development Agreement [Amendment No. 3], Manufacturing and Supply Agreement [Amendment No. 2] and License Agreement [Amendment No. 1] - Janssen Pharmaceutica International, Medisrb Technologies International, Alkermes Controlled Therapeutics Inc. II (Apr 1, 2000)
• Development Agreement [Amendment No. 4] and Manufacturing and Supply Agreement [Amendment No. 1] - Janssen Pharmaceutica International, Medisorb Technologies International and Alkermes Controlled Therapeutics Inc. II (Dec 20, 2000)
• Development and License Agreement - R. W. Johnson Pharmaceutical Research Institute and Alkermes Controlled Therapeutics Inc. (Jan 19, 1998)
• Discontinuation Agreement - Alkermes Inc. and Genentech Inc. (Apr 4, 1999)
• Employment Agreement - Alkermes Inc. and David A. Broecker (Dec 22, 2000)
• Employment Agreement - Alkermes Inc. and Kathryn L. Biberstein (Jan 8, 2003)
• Environmental Indemnity Agreement - Alkermes Inc., Alkermes Controlled Therapeutics Inc. II and Fleet National Bank (Sep 27, 1996)
• License Agreement - Alkermes Controlled Therapeutics Inc. and Genentech Inc. (Apr 14, 1999)
• License Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica Inc. (Feb 13, 1996)
• License Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica International (Feb 21, 1996)
• MA-Cambridge-281 Albany Street - Massachusetts Institute of Technology and Alkermes Inc. (Jul 26, 1993)
• MA-Cambridge-64 Sidney Street Lease - Forest City 64 Sidney Street Inc. and Alkermes Inc. (Oct 26, 2000)
• MA-Cambridge-88 Sidney Street Lease - FC 88 Sidney Inc. and Alkermes Inc. (Oct 26, 2000)
• Manufacture and Supply Agreement - Genentech Inc. and Alkermes Controlled Therapeutics Inc. (Jan 1, 2000)
• Manufacturing and Supply Agreement - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Aug 6, 1997)
• Manufacturing and Supply Agreement [Addendum] - JPI Pharmaceutical International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Aug 1, 2001)
• Manufacturing and Supply Agreement [Amendment No. 4] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. IIs (Jan 10, 2005)
• Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 21, 2002)
• Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 16, 2003)
• Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 22, 2003)
• Master Security Agreement - General Electric Capital Corp. and Alkermes Inc. (Dec 22, 2004)
• Patent License Agreement - Massachusetts Institute of Technology and Advanced Inhalation Research Inc. (Aug 11, 1997)
• Supply and License Agreement - R. W. Johnson Pharmaceutical Research Institute, Janssen Pharmaceutica International and Alkermes Inc. (Jan 19, 1998)

Allergan Ligand Retinoid Therapeutics Inc.

• Settlement Agreement and Mutual General Release - La Jolla Cancer Research Foundation, SelectRA Pharmaceuticals Inc. and SRI International, Ligand Pharmaceuticals Inc., Allergan Ligand and Allergan Ligand Retinoid Therapeutics Inc. (Aug 23, 1995)

Altana AG

• 3-Hybrid Collaboration and License Agreement - Altana Pharma AG, Altana Research Institute, GPC Biotech AG and GPC Biotech Inc. (Nov 6, 2003)
• Collaboration and License Agreement - BYK Gulden Lomberg Chemische Fabrik GmbH and GPC Biotech AG (Jul 11, 2001)
• Collaboration and License Agreement [Amendment No. 1] - BYK Gulden Lomberg Chemische Fabrik GmbH and GPC Biotech AG (Jun 30, 2002)
• Collaboration and License Agreement [Amendment No. 2] - Altana Pharma AG and GPC Biotech AG (Jan 31, 2003)

Alza Corp.

• Interim Development Agreement - Alza Corp. and BioMedicines Inc. (Nov 8, 2000)

Amgen Inc.

• Collaboration Agreement - Amgen Inc. and ViaCell Inc. (Dec 23, 2003)
• Collaboration and License Agreement - Tularik Inc. and Amgen Inc. (May 21, 2003)
• Warrant to Purchase Shares - ViaCell Inc. and Amgen Inc. (Apr 9, 2002)

Applied Molecular Evolution Inc.

• 2000 Employee Stock Purchase Plan - Applied Molecular Evolution Inc. (Jun 20, 2000)
• CA-San Diego-11095 Flintkote Avenue Lease - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Nov 20, 2000)
• CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 1] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Oct 1, 2002)
• CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 2] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Nov 14, 2002)
• CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 3] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Mar 14, 2003)
• CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 4] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Aug 4, 2003)
• CA-San Diego-3520 Dunhill Street Sublease [Amendment No. 4] - General Atomics and Applied Molecular Evolution Inc. (Sep 23, 2002)
• CA-San Diego-3520 Dunhill Street Sublease [Amendment No. 5] - General Atomics and Applied Molecular Evolution Inc. (Aug 20, 2003)
• CA-San Diego-3520/3550 Dunhill Street Lease - General Atomics and Ixsys Inc. (Jun 1, 1993)
• CA-San Diego-Torrey Hills Commercial Land Purchase and Sale Agreement - Westbrook Torrey Hills LP and Torrey View Phase II LP (Jul 10, 2001)
• CA-San Diego-Torrey Hills Commercial Land Purchase and Sale Agreement [Amendment No. 1] - AME Torrey View LLC and Westbrook Torrey Hills LP (Oct 11, 2001)
• CA-San Diego-Torrey Hills Lease Agreement - AME Torrey View LLC and Applied Molecular Evolution Inc. (Aug 20, 2001)
• Collaboration Agreement - Ixsys Inc. and Bio-Management Inc. (Nov 29, 1999)
• Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jun 5, 2000)
• Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jul 3, 2000)
• Employment Agreement - Applied Molecular Evolution Inc. and James B. Breitmeyer (Nov 20, 2001)
• Employment Agreement - Applied Molecular Evolution Inc. and William L. Respess (Jun 7, 2002)
• Engagement Letter and Compensation Agreement - AME Torrey View LLC and Irving Hughes (May 6, 2002)
• Indemnity Agreement - Applied Molecular Evolution Inc. (Jun 20, 2000)
• Lease - General Electric Capital Corp. and Applied Molecular Evolution Inc. (Sep 24, 2003)
• License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
• License Agreement - Ixsys Inc. and Stuart A. Kauffman (Nov 3, 1994)
• License Agreement - The Scripps Research Institute and Ixsys Inc. (May 20, 1994)
• Loan and Security Agreement - Silicon Valley Bank and Applied Molecular Evolution Inc. (Sep 29, 2003)
• Non-Exclusive License Agreement - Ixsys Inc. and Biosite Diagnostics Inc. (Sep 9, 1998)
• Pledge Agreement - Applied Molecular Evolution Inc. and Torrey View Phase II LP (Mar 4, 2002)
• Research and Assignment and License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
• Secured Promissory Note - Ocean Air Associates LLC and Applied Molecular Evolution Inc. (Mar 4, 2002)
• Selection Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
• Selection Agreement [Amendment] - MedImmune Inc. and Applied Molecular Evolution Inc. (Mar 8, 2001)
• Stock Purchase Agreement - Attenuon LLC and Applied Molecular Evolution Inc. (Nov 30, 2000)
• Stock Purchase Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
• Warrant to Purchase Stock - Ixsys Inc. and Silicon Valley Bank (Aug 30, 1996)
• Warrant to Purchase Stock - Ixsys Inc. and Silicon Valley Bank (Jun 23, 1997)

AstraZeneca plc

• Asset Purchase Agreement - AstraZeneca AB and NeoSan Pharmaceuticals Inc. (Jul 25, 2001)
• Asset Purchase Agreement [Amendment No. 1] - AstraZeneca AB and aaiPharma LLC (Jul 22, 2003)
• Collaboration Agreement - Maxygen Inc. and Zeneca Ltd. (Jun 18, 1999)
• Interim Supply Agreement [Amendment No. 1] - AstraZeneca LP and aaiPharma LLC (Jul 22, 2003)
• KBI Shares Option Agreement - Astra AB, Merck & Co. Inc. and Merck Holdings Inc. (Jul 1, 1998)
• KBI Supply Agreement - Astra Merck Inc. and Astra Pharmaceuticals LP (Jul 1, 1998)
• KBI-E Asset Option Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc. and Astra Merck Enterprises Inc. (Jul 1, 1998)
• License and Option Agreement - Astra AB and Astra Merck Inc. (Jul 12, 1982)
• Manufacturing Agreement - Merck & Co. Inc., Astra AB, Astra Merck Inc. and Astra USA Inc. (Jul 1, 1998)
• Master Restructuring Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc., Astra USA Inc., KB USA LP, Astra Merck Enterprises Inc., KBI Sub Inc., Merck Holdings Inc. and Astra Pharmaceuticals LP (Jun 19, 1998)
• Registration Rights Agreement - Maxygen Inc. (Nov 13, 2000)

Aventis

• Collaboration Agreement - Rhone-Poulenc Animal Nutrition SA and Diversa Corp. (Jun 28, 1999)
• License and Assignment Agreement - Sepracor Inc. and Rhone-Poulenc Rorer SA (Sep 30, 1999)

AVI BioPharma Inc.

• Common Stock and Warrant Purchase Agreement - SuperGen Inc. and AVI BioPharma Inc. (Apr 4, 2000)
• Sales, Distribution, and Development Agreement - AVI BioPharma Inc. and SuperGen Inc. (Apr 4, 2000)

Axm Pharma Inc.

• Agreement for Processing (OEM) - Shenyang Tianwei Werke Pharmaceutical Co. Ltd. and Qiqihaer No. 2 Pharmaceutical Factory (Sep 19, 2002)
• Agreement on Agency for Sale (Distribution) - Shenyang Tianwei Pharmaceutical Factory and Liaoning Weikang Medicine Co. Ltd. (Mar 30, 2004)
• Consulting Agreement - Axiom Pharmaceuticals Inc. and Amaroq Capital LLC (May 1, 2003)
• Consulting Agreement - Axiom Pharmaceuticals Inc. and Tripoint Capital Advisors LLC (Aug 25, 2003)
• Consulting Agreement - Axm Pharma Inc. and Aston Organization (Feb 2, 2004)
• Consulting Agreement - Madden Consulting Inc. and Axiom Pharmaceuticals Inc. (Apr 3, 2003)
• Corporate Consulting Services - Woodbridge Management Ltd. and Axiom Pharmaceuticals Inc. (Jun 27, 2003)
• Employment Agreement - Axiom Pharmaceutical Inc. and Peter W. Cunningham (Aug 1, 2003)
• Employment Agreement - Axiom Pharmaceuticals Inc. and Lan Hao (Sep 18, 2003)
• Investment Banking Service Agreement - Axm Pharma Inc. and Great Eastern Securities Inc. (Dec 18, 2003)

Bayer AG

• Collaboration Agreement - Pharmacopeia Inc. and Bayer Corp. (Dec 31, 1995)
• Random Library Agreement - Pharmacopeia Inc. and Bayer Corp. (Dec 31, 1995)

Biogen Idec Inc.

• Agreement and Plan of Merger - IDEC Pharmaceuticals Corp. and Biogen Inc. (Jun 20, 2003)
• Antegren Development and Marketing Collaboration Agreement - Biogen Inc. and Elan Pharma International Ltd. (Aug 15, 2000)
• CA-Del Mar-10996 Torreyana Road Lease - 10996 Torreyana Road LP and IDEC Pharmaceuticals Corp. (Jan 17, 2002)
• CA-Oceanside-Ocean Ranch Purchase Agreement and Escrow Instructions - Ivey Ranch Development Co. LLC and IDEC Pharmaceuticals Corp. (Aug 31, 2000)
• CA-San Diego-11011 Torreyana Road Lease Assignment and Asset Purchase Agreement - Tanox West Inc. and Biogen Idec Inc. (Dec 9, 2004)
• CA-San Diego-3030 Callan Road Lease - All Spectrum Services Inc. and IDEC Pharmaceuticals Corp. (Aug 13, 1996)
• CA-San Diego-Nobel Research Park Purchase and Sale Agreement and Escrow Instructions - San Dieguito Partnership LP and IDEC Pharmaceuticals Corp. (Jul 17, 2001)
• Collaboration & License Agreement - Schering AG and IDEC Pharmaceuticals Corp. (Jun 9, 1999)
• Collaborative Development Agreement - Mitsubishi-Tokyo Pharmaceuticals Inc. and IDEC Pharmaceuticals Corp. (Sep 21, 2001)
• Collaborative Development Agreement - Taisho Pharmaceutical Co. Ltd. and IDEC Pharmaceuticals Corp. (Dec 22, 1999)
• Collaborative Development Agreement [Addendum] - Seikagaku Corp. and IDEC Pharmaceuticals Corp. (Mar 22, 2002)
• Collaborative Research and License Agreement - IDEC Pharmaceuticals Corp. and SmithKline Beecham plc (Feb 29, 2000)
• Commercial Supply Agreement - Baxter Pharmaceutical Solutions LLC and IDEC Pharmaceuticals Corp. (Jun 1, 2002)
• Consulting Agreement - Biogen Inc. and Alexander Bearn (Apr 14, 1995)
• Consulting Agreement - Biogen Inc. and Alexander G. Bearn (Mar 24, 1998)
• Employment Agreement - Biogen Inc. and Hans-Peter Hasler (Jun 22, 2001)
• Employment Agreement - Biogen Inc. and Burt Adelman (Apr 2, 1996)
• Employment Agreement - Biogen Inc. and Hans-Peter Hasler (Oct 19, 2001)
• Employment Agreement - Biogen Inc. and Irvin D. Smith (Aug 30, 1993)
• Employment Agreement - Biogen Inc. and James C. Mullen (Mar 18, 1993)
• Employment Agreement - Biogen Inc. and James C. Mullen (Feb 15, 2002)
• Employment Agreement - Biogen Inc. and James C. Mullen (Mar 6, 2003)
• Employment Agreement - Biogen Inc. and James L. Vincent (Mar 10, 2000)
• Employment Agreement - Biogen Inc. and James L. Vincent (Jul 15, 2002)
• Employment Agreement - Biogen Inc. and James R. Tobin (Jan 12, 1994)
• Employment Agreement - Biogen Inc. and Kees Been (Jul 19, 1999)
• Employment Agreement - Biogen Inc. and M. W. Leuchtenberger (Nov 14, 1996)
• Employment Agreement - Biogen Inc. and Mark Leuchtenberger (May 12, 1999)
• Employment Agreement - Biogen Inc. and Peter Kellogg (Jun 21, 2000)
• Employment Agreement - Biogen Inc. and Peter Kellogg (Oct 19, 2001)
• Employment Agreement - Biogen Inc. and Sylvie Gregoire (May 19, 1998)
• Employment Agreement - Biogen Inc. and Sylvie Gregoire (Oct 19, 2001)
• Employment Agreement - Biogen Inc. and Thomas Bucknum (Oct 19, 2001)
• Employment Agreement - Biogen Inc. and Thomas J. Bucknum (Jun 11, 1999)
• Employment Agreement - Biogen Inc. and William Asher (Jul 15, 2002)
• Exclusive License and Development Agreement [Amendment] - Biogen Inc. and Schering Corp. (May 1, 1998)
• Independent Consulting Agreement - Biogen Inc. and Kenneth Murray (Sep 27, 2001)
• Independent Consulting Agreement - Biogen Inc. and Phillip A. Sharp (Dec 15, 1995)
• Independent Consulting Agreement - Biogen Inc. and Phillip A. Sharp (Dec 11, 1998)
• Independent Consulting and Project Agreement - Biogen Inc. and Kenneth Murray (Sep 23, 1995)
• Independent Consulting and Project Agreement - Biogen Inc. and Kenneth Murray (Sep 11, 1998)
• Isotope Agreement - MDS Nordion Inc. and IDEC Pharmaceuticals Corp. (May 14, 1999)
• Isotope Agreement [Amendment No. 3] - MDS (Canada) Inc. and IDEC Pharmaceuticals Corp. (Nov 12, 2001)
• License Agreement - Biogen Inc. and Tanox Biosystems Inc. (Jun 1, 1998)
• License Agreement - Taisho Pharmaceutical Co. Ltd. and IDEC Pharmaceuticals Corp. (Dec 22, 1999)
• Netherlands-Lijnden-Tokyostraat 27-33 Lease - TUG Vastgoed BV and Biogen Idec BV (Jul 2003)
• Stock Option Agreement - Biogen Inc. and James L. Vincent (Sep 22, 1995)
• Stock Option Agreement - Biogen Inc. and James L. Vincent (Dec 12, 1997)
• Supply Agreement - Catalytica Pharmaceuticals Inc. and IDEC Pharmaceuticals Corp. (Aug 2001)

Biopure Corp.

• 1998 Stock Option Plan - Biopure Corp.
• 2002 Omnibus Securities and Incentive Plan - Biopure Corp. (Apr 2, 2003)
• Agency Agreement - Biopure Corp. and The Butler Co. (Mar 29, 1999)
• Agreement - Moyer Packing Co. and Biopure Corp. (Oct 21, 1994)
• Agreement Concerning Sale of Common Stock - Biopure Corp. and Carl W. Rausch (Aug 27, 2003)
• Agreement of License Termination, Stock Repurchase and Mutual General Release - Biopure Corp., Biopure Europe Ltd. and B. Braun Melsungen AG (Aug 29, 1997)
• Agreement of Settlement and Mutual General Release - Biopure Corp., Biopure Associates LP and Credit Francais International SA (Dec 19, 1996)
• Assignment and Assumption of Deed of Easement - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
• By-Laws - Biopure Corp. (Jun 24, 1999)
• Consulting Agreement - Biopure Corp. and William D. Hoffman (Feb 17, 2000)
• Deferred Compensation Agreement - Biopure Corp. and Carl W. Rausch (Aug 8, 1990)
• Deferred Compensation Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
• Distribution Agreement - Network Healthcare Holdings Ltd. and Biopure Corp. (2000)
• Distribution Agreement [Amendment] - Network Healtcare Holdings Ltd., Tshepo Pharmaceuticals (Pty) Ltd. and Biopure Corp. (Mar 9, 2001)
• Employment Agreement - Biopure Corp. (1999)
• Employment Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
• Employment Agreement - Biopure Corp. and Daniel R. Davis (Dec 3, 1998)
• Employment Agreement - Biopure Corp. and Paul A. Looney (Jun 9, 1999)
• Employment Agreement - Biopure Corp. and Ronald F. Richards (Feb 12, 2003)
• Employment Agreement - Biopure Corp. and Thomas A. Moore (Jun 2002)
• Equity Line Financing Agreement - Biopure Corp. and Societe Generale (Jun 21, 2001)
• Escrow Agreement - B. Braun Melsungen AG, Biopure Corp. and State Street Bank and Trust Co. (Sep 2, 1997)
• Incentive Compensation Plan - Biopure Corp.
• Incentive Compensation and Company Stock Purchase Plan - Biopure Corp.
• License Agreement for Spur Facility - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
• License Agreement for Waste Disposal System - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
• Loan Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
• Lock-Up Agreement - Biopure Corp. and C. Everett Koop (Aug 1, 2003)
• Lock-Up Agreement - Biopure Corp. and Charles A. Sanders (Aug 1, 2003)
• Lock-Up Agreement - Biopure Corp. and David N. Judelson (Aug 4, 2003)
• Lock-Up Agreement - Biopure Corp. and Thomas A. Moore (Aug 4, 2003)
• MA-Cambridge-11 Hurley Street Lease - Eleven Hurley Street Associates and Biopure Corp. (Aug 29, 1994)
• MA-Cambridge-22 Spring Street Lease - Torvis Realty Trust and Biopure Corp. (Oct 12, 1990)
• MA-Cambridge-31/35 Hurley Street Lease - Tarvis Realty Trust and Biopure Corp. (May 10, 1994)
• MA-Cambridge-37/39 Hurley Street - Tarvis Realty Trust and Biopure Corp. (Aug 23, 1994)
• MA-Cambridge-58 Charles Street Sublease - Cendant Operations Inc. and Biopure Corp. (Jun 20, 2001)
• MA-Cambridge-84/86 Second Street Lease - Karpowicz Family Trust and Biopure Corp. (May 23, 1997)
• MA-Cambridge-Hurley Street Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• MA-Cambridge-Spring Street Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• NH-Dover-4 Progress Drive Lease Agreement - New England Innovations Corp. and Biopure Corp. (Mar 31, 1995)
• PA-Franconia Lease - Moyer Packing Co. and Biopure Corp. (Oct 21, 1994)
• PA-Franconia Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• Patent Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• Placement Agency Agreement - Biopure Corp. and Shoreline Pacific LLC (Apr 18, 2002)
• Placement Agency Agreement - DP Securities Inc. and Biopure Corp. (May 1, 2002)
• Placement Agent's Warrant - Biopure Corp. and DP Securities Inc. (May 9, 2002)
• Placement Agent's Warrant - Biopure Corp. and Shoreline Pacific LLC (Apr 23, 2002)
• Promissory Note - Biopure Corp. and Bing L. Wang (Jul 31, 1995)
• Promissory Note - Biopure Corp. and Brian A. Lajoie (Jul 31, 1995)
• Promissory Note - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
• Promissory Note - Biopure Corp. and Edward E. Jacobs Jr. (Jul 31, 1995)
• Promissory Note - Biopure Corp. and Geoffrey Filbey (Jul 31, 1995)
• Promissory Note - Biopure Corp. and James R. Weston (Jul 31, 1995)
• Promissory Note - Biopure Corp. and Maria S. Gawryl (Jul 31, 1995)
• Promissory Note - Biopure Corp. and Maria S. Gawryl (Jul 31, 2000)
• Promissory Note - Biopure Corp. and Pharmacia (Oct 8, 1996)
• Promissory Note [$1,009,772.01.] - Biopure Corp. and Carl W. Rausch (Jul 31, 1995)
• Promissory Note [$216,033.05] - Biopure Corp. and Carl W. Rausch (Jul 31, 1995)
• Purchase Agreement - Biopure Corp. and INPACO Corp. (Aug 28, 1997)
• Registration Rights Agreement - Biopure Corp. and Societe Generale (Jun 21, 2001)
• SC-Sumter Lease - Sumter Realty Group LLC and Biopure Corp. (Dec 24, 2002)
• Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• Severance Agreement - Biopure Corp. and Paul Looney (Jun 25, 2002)
• Stock Option Agreement - Biopure Corp. and Thomas A. Moore (Jun 25, 2002)
• Stock Purchase Agreement - Biopure Corp. and Geoffrey J. Filbey (May 1, 1999)
• Trademark Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
• Underwriting Agreement - Biopure Corp., J.P. Morgan Securities Inc., Salomon Smith Barney Inc. and Adams, Harkness & Hill Inc. (Mar 13, 2000)
• Warrant to Purchase Stock - Biopure Corp. and Network Healthcare Holdings Ltd. (Nov 1, 2000)
• Warrant to Purchase Stock - Biopure Corp. and Scanix Six (Pty) Ltd. (Nov 1, 2000)

BioReliance Corp.

• Agreement and Plan of Merger - Invitrogen Corp. and BioReliance Corp. (Dec 24, 2003)

Biosite Inc.

• Non-Exclusive License Agreement - Ixsys Inc. and Biosite Diagnostics Inc. (Sep 9, 1998)

Boehringer Ingelheim International GmbH

• Contract Research and Development Agreement - BioMedicines Inc. and Boehringer Ingelheim Pharma KG (Jul 17, 1998)
• Contract for Supply of Fudan New English Corporate E-Learning Solution - Shanghai Broadband Network Inc. and Boehringer Ingelheim Shanghai Pharmaceuticals Co. Ltd. (Jun 30, 2004)
• License Agreement - Boehringer Ingelheim International GmbH and BioMedicines Inc. (Jul 17, 1998)

Bristol-Myers Squibb Co.

• Collaboration and License Agreement - Pharmacopeia Inc. and Bristol-Myers Squibb Co. (Nov 26, 1997)
• Collaborative Research and License Agreement [Termination] - Bristol-Myers Squibb Co. and EntreMed Inc. (Aug 5, 1997)
• Collaborative Research, Development and Marketing Agreement [Amendment No. 4] - Mitotix Inc. and Bristol-Myers Squibb Pharma Co. (Dec 28, 2000)
• Research, Development and License Agreement - Bristol-Myers Squibb Co. and Ligand Pharmaceuticals Inc. (May 19, 2000)

Cambrex Corp.

• Manufacturing Services Agreement - Tercica Medica Inc. and Cambrex Bio Science Baltimore Inc. (Dec 20, 2002)
• Manufacturing Services Agreement [Exhibits] - Tercica Medica Inc. and Cambrex Bio Science Baltimore Inc. (Dec 20, 2002)

CancerVax Corp.

• 2000 Stock Incentive Plan - CancerVax Corp.
• 2003 Equity Incentive Award Plan - CancerVax Corp. (2003)
• 2003 Management Incentive Compensation Plan - CancerVax Corp. (2003)
• Agreement and Plan of Merger - CancerVax Corp. and Cell-Matrix Inc. (Jan 8, 2002)
• Bylaws - CancerVax Corp.
• CA-Carlsbad-2110 Rutherford Road Lease - Blackmore Airport Centre and CancerVax Corp. (Aug 31, 2001)
• CA-Marina del Rey-4503 Glencoe Avenue Lease - Spieker Properties LP and John Wayne Cancer Institute (Jul 22, 1999)
• CA-Marina del Rey-4503 Glencoe Avenue Lease [Amendment No. 1] - EOP-Marina Business Center LLC and CancerVax Corp. (Oct 1, 2001)
• CA-Marina del Rey-4503 Glencoe Avenue Lease [Amendment No. 2] - EOP-Marina Business Center LLC and CancerVax Corp. (Sep 4, 2002)
• CA-Marina del Rey-4503 Glencoe Avenue Lease [Assignment] - John Wayne Cancer Institute and CancerVax Corp. (Aug 4, 2000)
• CDL Agreement - Cancer Diagnostics Laboratories Inc. and CancerVax Corp. (Jul 31, 2000)
• CDL Agreement [Amendment No. 1] - Cancer Diagnostic Laboratories inc. and CancerVax Corp. (Dec 15, 2000)
• CDL Agreement [Amendment No. 2] - Cancer Diagnostic Laboratories Inc. and CancerVax Corp. (May 1, 2002)
• Certificate of Incorporation - CancerVax Corp. (Nov 3, 2003)
• Collaboration Agreement - Ixsys Inc. and Bio-Management Inc. (Nov 29, 1999)
• Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jun 5, 2000)
• Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jul 3, 2000)
• Consulting Agreement - CancerVax Corp. and Donald L. Morton (Dec 15, 2000)
• Contribution of Technology and Exchange Agreement - Donald L. Morton and CancerVax Corp. (Dec 15, 2000)
• Contribution of Technology and Exchange Agreement [Amendment No. 1] - Donald L Morton and CancerVax Corp. (May 1, 2002)
• Cross-License Agreement - CancerVax Inc. and the John Wayne Cancer Institute (Jul 24, 1998)
• Cross-License Agreement [Assignment] - 3DLM Inc., the John Wayne Cancer Institute and CancerVax Corp. (Jul 31, 2000)
• Development and Sublicensing Agreement - Cell-Matrix Inc. and Eyetech Pharmaceuticals Inc. (Mar 5, 2001)
• Employee Stock Purchase Plan - CancerVax Corp.
• Employment Agreement - CancerVax Corp. and David F. Hale (Oct 23, 2000)
• Employment Agreement - CancerVax Corp. and Debra J. Arnold (Feb 1, 2002)
• Employment Agreement - CancerVax Corp. and Dennis Van Epps (Nov 26, 2001)
• Employment Agreement - CancerVax Corp. and Guy Gammon (Jan 1, 2001)
• Employment Agreement - CancerVax Corp. and Hazel M. Aker (Feb 9, 2001)
• Employment Agreement - CancerVax Corp. and John Petricciani (Jan 5, 2001)
• Employment Agreement - CancerVax Corp. and Martin A. Mattingly (May 15, 2003)
• Employment Agreement - CancerVax Corp. and Robert L. Jones (Jan 15, 2001)
• Employment Agreement - CancerVax Corp. and William R. LaRue (Apr 2, 2001)
• Employment Agreement [Amendment No. 1] - CancerVax Corp. and David F. Hale (Apr 29, 2003)
• Fetal Antigen License Agreement - Donald L. Morton and CancerVax Corp. (Dec 15, 2000)
• Indemnification Agreement - CancerVax Corp. (2003)
• Letter Agreement - CancerVax Corp., the John Wayne Cancer Institute and Synteract Inc. (Jan 22, 2002)
• License Agreement - M-Tech Therapeutics Inc. and CancerVax Corp. (Oct 4, 2002)
• License Agreement - New York University and Cell-Matrix Inc. (Jun 2, 2003)
• License Agreement - Scripps Research Institute and Cell Matrix Inc. (2001)
• License Agreement - University of Southern California and Bio-Management Inc. (Sep 19, 1999)
• License Agreement - University of Southern California and Bio-Management Inc. (May 23, 2000)
• Loan and Security Agreement - CancerVax Corp. and Venture Lending & Leasing III Inc. (Sep 6, 2002)
• Master Services Agreement - CancerVax Corp., the John Wayne Cancer Institute and Synteract Inc. (Jan 22, 2002)
• Stockholders' Agreement - CancerVax Corp., the Morton Family Trust, the Morton Annuity Trust, OncoVac Inc. and the John Wayne Cancer Institute (Aug 13, 2003)
• Supply Agreement - Organon Teknika Corp. and CancerVax Inc. (Apr 15, 1998)
• Supply Agreement [Assignment] - 3DLM Inc. and CancerVax Corp. (Jul 31, 2000)

Celgene Corp.

• Agreement - Celgene Corp., Children's Medical Center Corp., Bioventure Investments kft and EntreMed Inc. (Aug 2001)
• Collaborative Research and License Agreement - Novartis Pharma AG and Celgene Corp. (Dec 20, 2000)
• Custom Manufacturing Agreement - Johnson Matthey Inc. and Celgene Corp. (Jun 1, 2000)
• Development and License Agreement - Celgene Corp. and Novartis Pharma AG (Apr 19, 2000)
• Distribution Services Agreement - Celgene Corp. and Ivers Lee Corp. d/b/a Sharp (Jun 2000)
• Distribution and Supply Agreement - Smithkline Beecham Corp. d/b/a GlaxoSmithKline and Celgene Corp (Mar 31, 2003)
• Employment Agreement - Celgene Corp. and John W. Jackson (Jan 1, 2000)
• Employment Agreement - Celgene Corp. and Robert J. Hugin (Jan 1, 2000)
• Employment Agreement - Celgene Corp. and Sol J. Barer (Jan 1, 2000)
• Exclusive License Agreement - Celgene Corp., Children's Medical Center Corp. and EntreMed Inc. (Dec 31, 2002)
• License Agreement - EntreMed Inc. and Celgene Corp. (Dec 9, 1998)
• Manufacturing and Supply Agreement - Celgene Corp. and Mikart Inc. (Apr 11, 2001)
• Securities Purchase Agreement - Pharmion Corp. and Celgene Corp. (Apr 8, 2003)
• Supply Agreement - Siegfried (USA) Inc. and Celgene Corp. (Jan 1, 2003)
• Supply Agreement - Sifavitor spa and Celgene Corp. (Sep 28, 1999)

Cell Genesys Inc.

• License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Sep 2, 1999)
• License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Mar 26, 2001)
• License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Jul 1, 2001)

Celltrion Inc.

• Assignment Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
• Consulting Services Agreement - VaxGen-Celltrion Inc. and VaxGen Inc. (Jun 7, 2002)
• Joint Venture Agreement - VaxGen Inc. and Celltrion Inc. (Jun 7, 2002)
• License Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
• License Agreement - VaxGen Inc. and VaxGen-Celltrion Inc. (Jun 7, 2002)
• Sub-License Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
• Sub-License Agreement - VaxGen Inc. and VaxGen-Celltrion Inc. (Jun 7, 2002)
• Supply Agreement - VaxGen inc. and Celltrion Inc. (Mar 25, 2002)

Centocor Inc.

• Sublicense Agreement - Centocor Inc. and MedImmune Inc. (Sep 15, 2000)

Cerus Corp.

• CA-Concord-2341 Stanwell Drive Lease - Holmgren Partners and Steritech Inc. (Feb 1, 1996)
• CA-Concord-2401 Stanwell Drive Lease - Cuff Trust and Steritech Inc. (Apr 29, 1982)
• CA-Concord-2411 Stanwell Drive Lease - Redwoods Office Center LP and Cerus Corp. (Dec 17, 1999)
• CA-Concord-2525 Stanwell Drive Lease - Shamrock Development Co. and Steritech Inc. (Oct 1, 1992)
• CA-Concord-2550 Stanwell Drive Lease - California Development Inc. and Cerus Corp. (Oct 12, 2001)
• Collaboration and License Agreement - Cerus Corp. and MedImmune Inc. (Apr 20, 2004)
• Collaborative License Agreement - Cerus Corp. and Kirin Brewery Co. Ltd. (Dec 31, 2000)
• Custom Synthesis Agreement - Steritech Inc. (Mar 14, 1996)
• Development, Manufacturing and Marketing Agreement - Baxter Healthcare Corp. and Steritech Inc. (Dec 13, 1993)
• Development, Manufacturing and Marketing Agreement - Baxter Healthcare Corp. and Steritech Inc. (Apr 1, 1996)
• Employment Agreement - Cerus Corp. and Claes Glassell (Aug 2, 2004)
• Employment Agreement - Cerus Corp. and Howard Ervin (May 28, 1999)
• License Agreement - Steritech Inc., Miles Inc. and Diamond Scientific Corp. (Nov 30, 1992)
• Research, Development, Reduction to Practice and Manufacturing Contract - Cerus Corp. (Oct 1, 1996)
• Supply Agreement - Steritech Inc. (Jul 18, 1994)

Chiron Corp.

• Asset Purchase Agreement - Chiron Diagnostics Corp., Chiron Corp. and Bio-Rad Laboratories Inc. (Dec 5, 1997)
• License Agreement - BioMedicines Inc. and Chiron Corp. (Nov 7, 2002)
• License Agreement - Cubist Pharmaceuticals Inc. and Chiron Healthcare Ireland Ltd. (Oct 2, 2003)
• License Agreement [Amendment No. 1] - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Apr 1, 2004)
• Manufacturing Services Agreement - Chiron Corp. and EntreMed Inc. (Apr 13, 2000)
• Manufacturing and Supply Agreement - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Oct 2, 2003)
• Research and Development License and Options for Commercial License - PanGenetics BV, Panorama Research Inc., Mark de Boer and Chiron Corp. (Sep 25, 1995)

Covance Inc.

• Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Oct 16, 1998)
• Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Jul 7, 1999)
• Letter of Intent - EntreMed Inc. and Covance Biotechnology Services Inc. (Aug 30, 1999)

Cubist Pharmaceuticals Inc.

• Agreement - Albany Molecular Research Inc. and Cubist Pharmaceuticals Inc. (Jul 30, 2001)
• Assignment and License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Oct 6, 2000)
• Assignment and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Eli Lilly and Co. (Jul 1, 2003)
• Audit Committee Charter - Cubist Pharmaceuticals Inc.
• Clinical Services Master Agreement - Cubist Pharmaceuticals Inc. and IBAH Inc. (Dec 1, 1999)
• Collaboration Agreement - Cubist Pharmaceuticals Inc. and Syrrx Inc. (Jun 27, 2001)
• Collaborative Research and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 4, 2002)
• Collaborative Research and License Agreement - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 3, 1999)
• Collaborative Research and License Agreement [Amendment No. 1] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Oct 30, 1997)
• Collaborative Research and License Agreement [Amendment No. 2] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Apr 30, 1998)
• Compound Library Screening Agreement - Genzyme Corp. and Cubist Pharmaceuticals Inc. (Feb 24, 1997)
• Contract Research Agreement - Target Research Associates Inc. and Cubist Pharmaceuticals Iinc. (Aug 1, 2000)
• Contract of Monitoring Services - Cubist Pharmaceuticals Inc. and Clindev (Pty) Ltd. (Jan 10, 2000)
• Credit Agreement - Cubist Pharmaceuticals Inc. and Citizens Bank of Massachusetts (Apr 30, 2003)
• Development and Supply Agreement - Cubist Pharmaceuticals Inc. and Abbott Laboratories (Apr 3, 2000)
• Employee Confidentiality Agreement - Cubist Pharmaceuticals Inc.
• Employment Agreement - Cubist Pharmaceuticals Inc. and Barry I. Eisenstein (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and Christopher D. T. Guiffre (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and David W. J. McGirr (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and Francis P. Tally (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and Michael W. Bonney (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and Oliver Fetzer (Jan 20, 2003)
• Employment Agreement - Cubist Pharmaceuticals Inc. and Scott M. Rocklage (Feb 25, 2003)
• Incentive Stock Option Agreement - Cubist Pharmaceuticals Inc. and Mark P. Carthy (May 19, 1997)
• Library Sample Evaluation Agreement - Pharmacopeia Inc. and Cubist Pharmaceuticals Inc. (Sep 11, 1996)
• License Agreement - Cubist Pharmaceuticals Inc. and Biochemie GmbH (Jul 31, 2002)
• License Agreement - Cubist Pharmaceuticals Inc. and Chiron Healthcare Ireland Ltd. (Oct 2, 2003)
• License Agreement - Cubist Pharmaceuticals Inc. and University of Utah (Dec 27, 2001)
• License Agreement - Cubist Pharmaceuticals Inc. and XTL Biopharmaceuticals Ltd. (Jun 2, 2004)
• License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Nov 7, 1997)
• License Agreement - International Health Management Associates Inc. and Cubist Pharmaceuticals Inc. (Nov 22, 2000)
• License Agreement [Addendum No. 1] - International Health Management Associates Inc. and Cubist Pharmaceuticals Inc. (Feb 28, 2003)
• License Agreement [Amendment No. 1] - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Apr 1, 2004)
• License Agreement [Amendment No. 1] - Cubist Pharmaceuticals inc. and Sandoz GmbH (Jul 16, 2003)
• MA-Lexington-45/55 Hayden Avenue Lease - California State Teachers' Retirement System and Cubist Pharmaceuticals Inc. (Aug 1, 2004)
• MA-Lexington-65 Hayden Avenue Purchase and Sale Agreement - Spaulding and Slye Hayden Woods LLC and Cubist Pharmaceuticals Inc. (Jul 28, 2000)
• Manufacturing and Supply Agreement - ACS Dobfar SpA and Cubist Pharmaceuticals Inc. (Sep 30, 2001)
• Manufacturing and Supply Agreement - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Oct 2, 2003)
• Manufacturing and Supply Agreement - DSM Capua SpA and Cubist Pharmaceuticals Inc. (Jun 22, 2000)
• Manufacturing and Supply Agreement [Amendment No. 2] - ACS Dobfar SpA and Cubist Pharmaceuticals Inc. (Feb 12, 2003)
• Marketing, Distribution and Development Agreement - Gilead Sciences Inc. and Cubist Pharmaceuticals Inc. (Jan 6, 2001)
• Master Lease Agreement - Transamerica Business Credit Corp. and Cubist Pharmaceuticals Inc. (Feb 7, 1997)
• Master Services Agreement - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Apr 25, 2001)
• Memorandum of Understanding - DSM Fine Chemicals Netherlands BV and Cubist Pharmaceuticals Inc. (Jan 26, 2000)
• Patent Cross-License Agreement - Terragen Discovery Inc. and Diversa Corp. (Nov 18, 1999)
• Research Collaboration and License Agreement - ArQule Inc. and Cubist Pharmaceuticals Inc. (Oct 22, 1997)
• Research Collaboration and License Agreement - Cubist Pharmaceuticals Inc. and Novalon Pharmaceutical Corp. (May 5, 1997)
• Research and Development Collaboration and Option Agreement - Emisphere Technologies Inc. and Cubist Pharmaceuticals Inc. (Sep 2000)
• Restricted Stock Agreement - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
• Screening Service Agreement - Cetek Corp. and Cubist Pharmaceuticals Inc. (Dec 7, 2001)
• Secured Promissory Note - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
• Secured Promissory Note - Cubist Pharmaceuticals Inc. and Mark P. Carthy (May 19, 1997)
• Services Agreement - Gist-brocades Holding AG and Cubist Pharmaceuticals Inc. (Jun 22, 2000)
• Stock Pledge Agreement - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
• Stock Purchase Agreement - Novartis Pharma AG and Cubist Pharmaceuticals Inc. (Feb 1999)
• UK-Berkshire-Slough-Trading Estate-250 Bath Road Lease - Slough Trading Estate Ltd., Cubist Pharmaceuticals (UK) Ltd. and Cubist Pharmaceuticals Inc. (Feb 20, 2002)
• Work Order - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Jun 7, 2001)

CytRx Corp.

• Agreement and Plan of Merger - CytRx Corp. and Global Genomics Capital Inc. (Feb 11, 2002)
• Agreement of Settlement and Release - CytRx Corp., Corporate Capital Group International Ltd. and Peter Simone (Aug 8, 2003)
• Asset Purchase Agreement - Proceutics Inc. and Oread Laboratories Inc. (Feb 10, 1998)
• Change In Control Employment Agreement - CytRx Corp. and Jack J. Luchese (Apr 16, 1997)
• Change In Control Employment Agreement - CytRx Corp. and Jack J. Luchese (Sep 1, 1999)
• Change in Control Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Jan 1, 2002)
• Common Stock Purchase Agreement - CytRx Corp., Celeste Trust Reg., AMRO International SA and Balmore Funds SA (Mar 24, 2000)
• Consulting/Engagement Agreement - Corporate Capital Group International Inc. and CytRx Corp. (Feb 21, 2003)
• Employment Agreement - Araios Inc. and Mark A. Tepper (Sep 17, 2003)
• Employment Agreement - CytRx Corp. and C. Kirk Peacock (Aug 1, 2003)
• Employment Agreement - CytRx Corp. and Jack J. Luchese (Mar 1995)
• Employment Agreement - CytRx Corp. and Jack J. Luchese (Sep 1, 1999)
• Employment Agreement - CytRx Corp. and Steven A. Kriegsman (May 2002)
• Employment Agreement - CytRx Corp. and Steven A. Kriegsman (Jun 10, 2003)
• Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Apr 16, 1997)
• Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Jan 1, 2002)
• Engagement Agreement - Cappello Capital Corp. and CytRx Corp. (Jan 1, 2002)
• Engagement Letter - CytRx Corp. and Cappello Capital Corp. (May 16, 2003)
• Engagement Letter - CytRx Corp. and Cappello Capital Corp. (Sep 19, 2003)
• Engagement Letter - CytRx Corp. and Cardinal Securities LLC (May 27, 2003)
• Engagement Letter - CytRx Corp. and Sands Brothers & Co. Ltd. (Sep 12, 2002)
• Engagement Letter [Amendment] - CytRx Corp. and Cardinal Securities LLC (Jun 6, 2003)
• Financial Consulting Agreement - CytRx Corp. and James Skalko (May 10, 2003)
• GA-Norcross-150 Technology Parkway Lease - Proceutics Inc. and Oread Inc. (Feb 1998)
• GA-Norcross-150 Technology Parkway Sublease - Oread Inc. and CytRx Corp. (Feb 16, 1998)
• Independent Contractor Agreement - CytRx Corp. and Louis J. Ignarro (Jul 17, 2003)
• Investment Banking Agreement - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
• Investment Banking Agreement - CytRx Corp. and Rockwell Asset Management Inc. (Apr 1, 2003)
• Investment Banking Agreement [Amendment No. 1] - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
• Investment Banking Agreement [Amendment No. 2] - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
• License Agreement - CytRx Corp. and Ivy Animal Health Inc. (Feb 16, 2001)
• License Agreement - University of Massachusetts and CytRx Corp. (Sep 15, 2003)
• Marketing Agreement - Madison & Wall Worldwide Inc. and CytRx Corp. (Aug 14, 2002)
• Office Space Agreement - Kriegsman Capital Group LLC and CytRx Corp. (Feb 11, 2002)
• Option Agreement - PSMA Development Co. LLC and CytRx Corp. (Dec 23, 2002)
• Placement Agent Agreement - CytRx Corp. and Dunwoody Brokerage Services Inc. (Sep 15, 2003)
• Placement Agent Agreement - CytRx Corp. and Gilford Securities Inc. (Sep 15, 2003)
• Preferred Stock Purchase Agreement - Araios Inc. and CytRx Corp. (Sep 16, 2003)
• Private Placement Agent Agreement - CytRx Corp. and Maxim Corp. LLC (Sep 16, 2003)
• Professional Services Agreement - CytRx Corp., The Kriegsman Group and Kriegsman Capital Group (Jan 29, 2003)
• Stockholders Agreement - Araios Inc. and CytRx Corp. (Sep 17, 2003)
• Supply Agreement - CytRx Corp. and Nycomed Inc. (Aug 30, 1999)

Daiichi Pharmaceutical Corp.

• Collaboration Agreement - Pharmacopeia Inc. and Daiichi Pharmaceutical Co. Ltd. (Mar 29, 1996)
• Collaboration Agreement - Rigel Pharmaceuticals Inc. and Daiichi Pharmaceutical Co. Ltd. (Aug 1, 2000)

deCODE genetics Inc.

• 2002 Equity Incentive Plan - deCODE genetics Inc. (Aug 30, 2002)
• Agreement - University of Iceland, Islensk Erfdagreining ehf. and the City of Reykjavik (Feb 15, 2000)
• Agreement Relating to the Issue of an Operating Licence for the Creation and Operation of a Health Sector Database - Minister for Health and Social Security and Islensk Erfdagreining ehf. (Jan 21, 2000)
• Agreement on the Creation of a Database of Icelandic Genealogy - Fridrik Skulason and Islensk Erfdagreining (Apr 15, 1997)
• Agreement on the Details of the Arrangement of Encumbrances in the Site Agreement - University of Iceland, Islensk Erfoagreining ehf. and the City of Reykjavik (Feb 15, 2000)
• Agreement on the Details of the Arrangement of Encumbrances in the Site Agreement [Annex] - University of Iceland, Islensk erfoagreining ehf. and the City of Reykjavik (Jan 4, 2002)
• Agreement on the Sale and Listing of Bonds - Islandsbanki FBA hf. and Islensk Erfoagreining ehf. (Dec 21, 2001)
• Co-operation Agreement - Akureyri Central Hospital and Islensk Erfdagreining ehf. (Oct 26, 1999)
• Co-operation Agreement - Reykjavik Hospital and Islensk Erfdagreining ehf. (Nov 4, 1998)
• Co-operation Agreement - The Icelandic State Hospital and Islensk Erfdagreining ehf. (Dec 15, 1998)
• Collaboration Agreement - Collaborative Group on Alzheimer's Disease and Related Disorders and Islensk Erfdagreining ehf. (Jul 19, 1998)
• Collaboration Agreement - Genmab A/S, Medarex Inc., Genpharm International Inc. and deCODE genetics ehf. (Jun 12, 2001)
• Collaboration Agreement - Helgi Jonsson, Thorvaldur Ingvarsson and Islensk Erfdagreining ehf. (Mar 31, 1998)
• Collaboration Agreement - The Icelandic Heart Association, Hjartavernd and Islensk Erfdagreining ehf. (Feb 13, 1998)
• Collaboration Agreement - The Research Group on Arterial Hypertension and Islensk Erfdagreining ehf. (Jun 3, 1998)
• Collaboration Agreement - The Research Group on Osteoporosis and Islensk Erfdagreining ehf. (Jul 19, 1998)
• Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd. AG and deCODE genetics ehf. (Jun 29, 2001)
• Consultancy Contract - deCODE genetics Inc. and Vane Associates (Dec 1, 1997)
• Consultancy Contract - deCODE genetics Inc. and Vane Associates (Aug 30, 2002)
• Contract Services Agreement - Encode ehf. and Genmab A/S (Jun 12, 2001)
• Contract on Financial Leasing - Lysing hf and Islensk Erfdagreining ehf. (Jun 19, 1998)
• Contract on Financial Leasing - Lysing hf. and Islensk Erfoagreining ehf. (Dec 31, 2001)
• Contract on the Processing of Clinical Data and Their Transfer to a Health Sector Database - Islensk Erfoagreining ehf.
• Crosswalk Development Agreement - Partners HealthCare System Inc., The General Hospital Corporation d/b/a Massachusetts General Hospital, The Brigham and Women's Hospital Inc. and deCODE genetics Ltd. (May 11, 2000)
• Currency Swap Agreement - Sturlugata 8 ehf. and Islandsbanki-FBA hf. (Dec 27, 2001)
• Currency Swap Agreement - Vetrargarourinn ehf. and Islandsbanki-FBA hf. (Mar 13, 2002)
• Directorship Agreement - deCODE genetics Inc. and J. Neal Armstrong (Aug 18, 2003)
• Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and C. Augustine Kong (Jan 1, 2001)
• Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and Lance Thibault (Feb 1, 2001)
• Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and Mark Gurney (Aug 21, 2000)
• Employment Agreement - deCODE genetics Inc. and Chung Tung Augustine Kong (Dec 30, 2000)
• Employment Agreement - deCODE genetics Inc. and Michael W. Young (Jun 4, 2001)
• Employment Agreement - deCODE genetics Ltd. and Einar Stefansson (Nov 22, 2000)
• Employment Agreement - deCODE genetics ehf. and Hakon Guobjartsson (May 5, 1999)
• Employment Contract - Islensk Erfdagreining ehf. and Sigurdur Ingibergur Bjornsson (Jan 15, 1999)
• Employment Contract - Islensk Erfoagreining ehf. and Hakon Hakonarson (Jul 23, 2003)
• Employment Contract - deCODE genetics ehf. and Axel Nielsen (Jul 1, 1998)
• Employment Contract - deCODE genetics ehf. and Kristjan Erlendsson (Sep 4, 1998)
• Founder Stock Purchase Agreement - deCODE genetics Inc. and Jeffrey R. Gulcher (Aug 21, 1996)
• Iceland-Kopavogur-Hlidarsmari 19 Lease - Computer Centre of the Icelandic Savings Banks and Islensk Erfdagreining ehf. (Nov 24, 1999)
• Iceland-Kopavogur-Hlidarsmari 19 Lease - Fridar sf. and Islensk Erfdagreining ehf. (Feb 18, 1999)
• Iceland-Kopavogur-Hlioarsmari 15 Lease - Veigur ehf and Islensk Erfoagreining hf. (Apr 2000)
• Iceland-Kopavogur-Hlioarsmari 17 Lease - Miojan ehf. and Islensk Erfoagreining ehf. (Mar 1, 2000)
• Iceland-Reykjavik-Lynghals 1 Contract on Sale and Leaseback - The Icelandic Investment Bank and Islensk Erfdagreining ehf. (Jun 8, 1998)
• Iceland-Reykjavik-Sturlugata No. 8 Lease - Islensk Erfoagreining ehf., University of Iceland and the City of Reykjavik (Oct 3, 2000)
• Indemnity Agreement - deCODE genetics Inc. and John Vane (Dec 1, 1997)
• Joint Development and Commercialization Agreement - deCODE genetics ehf. and PE Corp. (Jul 16, 2001)
• License Agreement - Islensk Erfdagreining ehf.
• Loan Agreement - Islandsbanki-FBA hf. and Sturlugata 8 ehf. (Dec 21, 2001)
• Loan Agreement - Islandsbanki-FBA hf. and Sturlugata 8 ehf. (Dec 27, 2001)
• Loan Agreement - Islensk Erfoagreining ehf. and Kristjan Erlendsson (Oct 15, 2001)
• Loan Agreement - Vetrargarourinn ehf. and Islandsbanki hf. (Mar 13, 2002)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Einar Stefansson (Dec 21, 2000)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Hakon Guobjartsson (Jan 29, 1998)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Mar 24, 1999)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Sep 15, 1999)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Jan 1, 2001)
• Non-Recourse Promissory Note - deCODE genetics Inc. and Sigurdur I. Bjornsson (Mar 24, 1999)
• Non-Statutory Stock Option Agreement - deCODE genetics Inc.
• Operating License for the Creation and Operation of a Health Sector Database - Minister for Health and Social Security and Islensk Erfdagreining ehf (Jan 22, 2000)
• Pharmacogenomics Collaboration and License Agreement - Encode ehf. and Affymetrix Inc. (Jul 16, 2001)
• Promissory Note - deCODE genetics Inc. and Hakon Gudbjartsson (May 27, 2002)
• Property Lien - Sturlugata 8 ehf. and Islandsbanki-FBA hf. (Dec 21, 2001)
• Property Lien - Vetrargarourinn ehf. and Islandsbanki-FBA hf. (Feb 28, 2002)
• Reagent Supply Agreement - deCODE genetics ehf. and PE Corp. (Jul 16, 2001)
• Research Agreement - Rannsokna-og Fredsluejodurinn ehf and deCODE genetics Inc. (Oct 24, 1997)
• Research Collaboration Agreement - Islenskar Hveraorverur ehf. and Islensk Erfdagreining ehf. (Dec 28, 1999)
• Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics Inc. (Feb 1, 1998)
• Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics ehf. (Feb 1, 2002)
• Research Collaboration and License Agreement - deCODE genetics Inc., deCODE genetics ehf. and Merck & Co. Inc. (Sep 26, 2002)
• Research Contract - Research Team for Age-Related Macular Degeneration and Islensk Erfdagreining ehf. (Apr 27, 1999)
• Research Contract - Research Team for Allergy and Asthma and Islensk Erfdagreining ehf. (Aug 20, 1999)
• Research Contract - Research Team for Cerebral Haemorrhage and Islensk Erfdagreining ehf. (Nov 3, 1999)
• Research Contract - Research Team for Chronic Obstructive Pulmonary Disease and Islensk Erfoagreining ehf. (Aug 20, 1999)
• Research Contract - Research Team for Epidemiology and Heredity of Lung Cancer and Islensk Erfoagreining ehf. (Jun 29, 2000)
• Research Contract - Research Team for Peripheral Artery Occlusive Disease and Islensk Erfdagreining ehf. (May 28, 1999)
• Settlement Agreement - The Beth Israel Deaconess Medical Center and deCODE genetics Inc. (Dec 31, 1997)
• Stock Purchase Agreement - Islensk Erfoagreining ehf., Kace Traders Ltd., Einar Stefansson and Thorsteinn Loftsson (Nov 8, 2000)
• Stock and Warrant Purchase Agreement - Roche Finance Ltd. and deCODE genetics Inc. (Feb 1, 1998)
• Strategic Alliance Agreement - Partners Healthcare System Inc., The General Hospital Corporation d/b/a Massachusetts General Hospital, The Brigham and Women's Hospital Inc. and deCODE genetics Ltd. (May 11, 2000)
• Work Contract - Islensk Erfdagreining ehf. and Eykt ehf. (Mar 15, 2001)

Delcath Systems Inc.

• Consulting Services Agreement - Delcath Systems Inc. and Euroland Marketing Solutions Ltd. (Jan 5, 2001)
• Engagement Agreement - Delcath Systems Inc. and Redington inc. (Nov 1, 2000)
• Exclusive Distributorship Agreement - Nissho Corp. and Delcath Systems Inc. (Dec 27, 1996)
• Warrant Agreement - Delcath Systems inc. and Euroland Marketing Solutions Ltd. (Jan 5, 2001)

diaDexus Inc.

• CA-South San Francisco-343 Oyster Point Boulevard Sublease - diaDexus Inc. and ViroLogic Inc. (Jun 1, 2002)
• CA-South San Francisco-343 Oyster Point Boulevard Sublease [Amendment No. 1] - diaDexus Inc. and ViroLogic Inc. (Aug 31, 2003)
• CA-South San Francisco-343 Oyster Point Boulevard Sublease [Termination] - Virologic Inc. and diaDexus Inc. (Jun 1, 2002)

Diversa Corp.

• Asset Sale Agreement - Diversa Corp. and Glaxo Wellcome SA (Jul 18, 2003)
• CA-San Diego-10655/10665/10675 Sorrento Valley Road Lease - Sycamore/San Diego Investors and Recombinant BioCatalysis Inc. (Sep 24, 1996)
• CA-San Diego-Sorrento Gateway Building A Lease - KR-Gateway Partners and Diversa Corp. (Feb 11, 2000)
• CA-San Diego-Sorrento Gateway Building B Lease - KR-Gateway Partners and Diversa Corp. (Feb 11, 2000)
• Collaboration Agreement - Glaxo Research and Development Ltd., Glaxo Group Ltd. and Diversa Corp. (Dec 8, 2000)
• Collaboration Agreement - Novartis Agribusiness Biotechnology Research Inc. and Diversa Corp. (Jan 25, 1999)
• Collaboration Agreement - Rhone-Poulenc Animal Nutrition SA and Diversa Corp. (Jun 28, 1999)
• Collaborative DNA Sequencing Agreement - Diversa Corp. and PE Corp. (NY) (Dec 1, 2000)
• Collaborative Research Agreement - Dow Chemical Co. and Diversa Corp. (Jul 22, 1999)
• Drug Discovery, Development, and License Agreement - Diversa Corp. and IntraBiotics Pharmaceuticals Inc. (Jan 6, 2001)
• Employment Agreement - Diversa Corp. and Jay M. Short (Jun 25, 1998)
• Employment Agreement - Diversa Corp. and Karin Eastham (Apr 2, 1999)
• Employment Agreement - Diversa Corp. and William H. Baum (Jul 31, 1997)
• Employment Agreement - Industrial Genome Sciences and Jay Short (Aug 30, 1994)
• Employment Agreement - Recombinant Biocatalysis Inc. and R. Patrick Simms (Feb 3, 1997)
• Joint Venture Agreement - Diversa Corp. and Novartis Seeds AG (Dec 1, 1999)
• License Agreement - Diversa Corp. and Finnfeeds International Ltd. (Dec 1, 1998)
• License Agreement - Dow Chemical Co. and Diversa Corp. (Jul 22, 1999)
• License Agreement - Invitrogen Corp. and Diversa Corp. (Mar 29, 1999)
• License Agreement - New Venture LLC and Diversa Corp. (Jun 29, 2000)
• License Agreement [Amendment No. 2] - Mycogen Corp. and Diversa Corp. (Mar 6, 1998)
• Limited Liability Company Agreement - New Venture LLC, Diversa Corp. and Dow Chemical Co. (Jun 29, 2000)
• Master Collaboration Agreement - Diversa Corp. and Dow Chemical Co. (Sep 1, 2000)
• Master Lease Agreement - Diversa Corp. and Transamerica Business Credit Corp. (Apr 13, 1999)
• Patent Cross-License Agreement - Terragen Discovery Inc. and Diversa Corp. (Nov 18, 1999)
• Project Agreement - Dow Chemical Co. and Diversa Corp. (Nov 30, 2000)
• Research Agreement - New Venture LLC and Diversa Corp. (Jun 29, 2000)
• Research Lease - One Cell Systems Inc. and Diversa Corp. (Feb 16, 1999)
• Research and Development Agreement - Novartis Enzymes Inc. and Diversa Corp. (Dec 1, 1999)
• Separation Agreement - Diversa Corp. and Kathleen H. Van Sleen (Mar 15, 1999)
• Separation Agreement - Diversa Corp. and Terrance J. Bruggeman (Feb 4, 1999)
• Stock Purchase Agreement - Diversa Corp. and Novartis Agribusiness Biotechnology Research Inc. (Jan 25, 1999)

DrugAbuse Sciences Inc.

• Agreement - Universite Paris V, DrugAbuse Sciences SAS and DrugAbuse Sciences Inc. (Jun 8, 1999)
• Agreement for The Transfer of Scientific and Technical Knowledge and for The Commercial Exploitation of Research Results - Universite Paris V, DrugAbuse Sciences SAS and DrugAbuse Sciences Inc. (Mar 3, 2000)
• CA-Los Altos-330 Distel Circle Lease - Midpeninsula Regional Open Space District and DrugAbuse Sciences Inc. (Feb 9, 2000)
• CA-Menlo Park-1430 O'Brien Drive Sublease - Menlo Business Park and DrugAbuse Sciences Inc. (Oct 1, 1998)
• Clinical Supply Agreement - DrugAbuse Sciences Inc. and SP Pharmaceuticals LLC (Nov 24, 1999)
• Employment Agreement - DrugAbuse Sciences Inc. and Donald R. Wesson (Oct 18, 1999)
• Employment Agreement - DrugAbuse Sciences Inc. and Elizabeth Greetham (Feb 4, 2000)
• Employment Agreement - DrugAbuse Sciences Inc. and Jacques Kusmierek (Dec 28, 1999)
• Employment Agreement - DrugAbuse Sciences Inc. and James W. Elder (Dec 27, 1999)
• Employment Agreement - DrugAbuse Sciences Inc. and Jason A. Gross (Dec 29, 1999)
• Employment Agreement - DrugAbuse Sciences Inc. and Laurent Chardonnet (Mar 27, 2000)
• Employment Agreement - DrugAbuse Sciences Inc. and Stanley A. Kaplan (Dec 26, 1999)
• Employment Agreement - DrugAbuse Sciences SAS and Maryvonne Hiance (Jun 9, 1999)
• France-Paris-48-50 Rue Boissonnade Lease - Financiere ETS and DrugAbuse Sciences (Feb 1, 2000)
• License Agreement - Abbott Laboratories and DrugAbuse Sciences Inc. (Aug 16, 2000)
• License Agreement - The Scripps Research Institute and DrugAbuse Sciences Inc. (Jun 18, 1996)
• Manufacturing and Supply Agreement - Pasteur Merieux Serums & Vaccins, DrugAbuse Sciences SA and DrugAbuse Sciences Inc. (Jun 8, 1999)
• Patent and Know-How License Agreement - Pasteur Merieux Serums & Vaccins and DrugAbuse Sciences Inc. (Jun 8, 1999)
• Product License Agreement - Southern Research Institute and Drug Abuse Sciences Inc. (2000)
• Product License Agreement - Southern Research Institute and DrugAbuse Sciences Inc. (Jul 1, 1999)
• Research Agreement With Option to License - Southern Research Institute and DrugAbuse Sciences Inc. (Feb 13, 1997)
• Research Agreement With Option to License - Southern Research Institute and DrugAbuse Sciences Inc. (Jan 21, 2000)
• Supply Agreement - Pharmaceutical Group of Mallinckrodt Inc. and DrugAbuse Sciences Inc. (Jun 9, 2000)
• Supply and Manufacturing Agreement - DrugAbuse Sciences Inc. and Eon Labs Manufacturing Inc. (Jul 20, 2000)

Elan Corp. plc

• Antegren Development and Marketing Collaboration Agreement - Biogen Inc. and Elan Pharma International Ltd. (Aug 15, 2000)
• Asset Purchase Agreement - Elan Corp. plc, Elan Pharma International Ltd., Elan Pharmaceuticals Inc., King Pharmaceuticals Inc., Jones Pharma Inc. and Monarch Pharmaceuticals Inc. (May 19, 2003)
• Asset Purchase Agreement - Elan Corp. plc, Elan Pharmaceuticals Inc., Elan Operations Inc., Elan Canada Inc. and Enzon Inc. (Oct 1, 2002)
• CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Jun 24, 2002)
• CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Mar 21, 2003)
• Consulting Agreement - Athena Neurosciences Inc. and Dennis J. Selkoe (Jul 1, 1986)
• Consulting Agreement - Dennis J. Selkoe and Elan Pharmaceuticals Inc. (Apr 1, 2002)
• Development, Licence and Supply Agreement [Amendment] - Elan Corp. plc and Ligand Pharmaceuticals Inc. (Aug 20, 1999)
• Distributorship Agreement - Ligand Pharmaceuticals Inc. and Elan Pharma International Ltd. (Feb 28, 2001)
• Incentive Agreement - Monksland Holdings BV, Elan International Services Ltd. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
• Investors' Rights Agreement - Nanogen Inc., Enterprise Management Partners, Kleiner Perkins Caufield & Byers, InterWest Partners, Sprout Group, DLJ Capital Corp., National Union Fire Insurance Co. of Pittsburgh, PA., Elan International Services Ltd., Integral Capital Partners, MDS Inc., Vulcan Ventures Inc. and Oracle Partners (May 5, 1997)
• License Agreement - Elan Pharmaceutical Technologies and Ligand Pharmaceuticals Inc. (Sep 28, 1998)
• Research and Development Agreement - Nanogen Inc. and Elan Corp. plc (Dec 12, 1997)

Eli Lilly and Co.

• Assignment and License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Oct 6, 2000)
• Assignment and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Eli Lilly and Co. (Jul 1, 2003)
• Exclusive License Agreement - Eli Lilly & Co. and Sepracor Inc. (Dec 4, 1998)
• License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Nov 7, 1997)
• Licensing Agreement - Eli Lilly and Co. and Tularik Inc. (Sep 24, 1999)
• Licensing Agreement [Amendment No. 1] - Tularik Inc. and Eli Lilly and Co. (Jan 10, 2001)
• Option and Wholesale Purchase Agreement - Eli Lilly and Co. and Ligand Pharmaceuticals Inc. (Nov 25, 1997)

Emergent BioSolutions Inc.

• Agreement - Free State of Bavaria and VIVACS GmbH (Jun 16, 2005)
• BT Vaccine Development Agreement - Emergent BioSolutions Inc. and the Health Protection Agency (Nov 23, 2004)
• BioThrax Vaccine Supply Agreement - BioPort Corp. and Centers for Disease Control and Prevention (May 5, 2005)
• Consulting Services Agreement - Emergent BioSolutions Inc. and Hauer Group (Mar 1, 2006)
• Employment Agreement - Emergent BioSolutions Inc. and Fuad El-Hibri (Aug 9, 2006)
• Employment Agreement - Emergent BioSolutions Inc. and Steven Chatfield (Jul 11, 2006)
• Employment Contract - Emergent Europe Ltd. and Steven N. Chatfield (Dec 22, 2005)
• Employment Contract - Emergent Product Development UK Ltd. and Steven N. Chatfield (Sep 21, 2006)
• Exclusive Distribution Agreement - Emergent BIoSolutions Inc. and Health Protection Agency (Nov 23, 2004)
• Filling Services Agreement - BioPort Corp. and Hollister-Stier Laboratories LLC (Mar 18, 2002)
• Licence and Co-Development Agreement - Emergent Europe Ltd. and Sanofi Pasteur SA (May 6, 2006)
• MD-Rockville-2273 Research Boulevard Lease - Brandywine Research LLC and Emergent BioSolutions Inc. (Jun 27, 2006)
• Marketing Agreement - BioPort Corp. and Intergen NV (Jan 1, 2000)
• Product Supply Agreement - Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc. (Jun 12, 2006)
• Services Agreement - East West Resources Corp. and Emergent BioSolutions Inc. (Aug 1, 2006)
• Severance Plan and Termination Protection Program - Emergent BioSolutions Inc.
• UK-Berkshire-Wokingham-Winnersh Triangle-Winnersh 540 Lease - Slough Properties Ltd. and Azur Environmental Ltd. (Dec 13, 1996)
• rBOT Vaccine License Agreement - Emergent BioSolutions Inc. and the Health Protection Agency (Nov 23, 2004)

EntreMed Inc.

• Agreement - Celgene Corp., Children's Medical Center Corp., Bioventure Investments kft and EntreMed Inc. (Aug 2001)
• Agreement - Cytokine Securities Inc. and Innovative Therapeutics Inc. (Jul 2, 1996)
• Analog Agreement - Children's Medical Center Corp. and EntreMed Inc. (Aug 6, 2001)
• Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Oct 16, 1998)
• Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Jul 7, 1999)
• Change in Control Agreement - EntreMed Inc. and Neil J. Campbell (Aug 1, 2002)
• Collaborative Research and License Agreement [Termination] - Bristol-Myers Squibb Co. and EntreMed Inc. (Aug 5, 1997)
• Confidential Separation Agreement and General Release - EntreMed Inc. and Edward R. Gubish (Sep 18, 2002)
• Employment Agreement - Cytokine Sciences Inc. and Charles Kirkpatrick (Jul 2, 1996)
• Employment Agreement - EntreMed Inc. and John W. Holaday Jr. (Jan 1, 1999)
• Employment Agreement - EntreMed Inc. and Neil J. Campbell (Apr 30, 2003)
• Exclusive License Agreement - Celgene Corp., Children's Medical Center Corp. and EntreMed Inc. (Dec 31, 2002)
• Letter of Intent - EntreMed Inc. and Covance Biotechnology Services Inc. (Aug 30, 1999)
• License Agreement - Children's Medical Center Corp. and EntreMed Inc. (Dec 5, 1996)
• License Agreement - Children's Medical Center Corp. and EntreMed Inc. (Dec 20, 1996)
• License Agreement - EntreMed Inc. and Celgene Corp. (Dec 9, 1998)
• MD-Rockville-9640 Medical Center Drive Lease - Red Gate III LP and EntreMed Inc. (Jun 10, 1998)
• Manufacturing Services Agreement - Chiron Corp. and EntreMed Inc. (Apr 13, 2000)
• Master Consulting Agreement - Interneuron Pharmaceuticals Inc. and Quintiles Inc. (Jul 12, 1996)
• Purchase Agreement - Bioventure Investments kft and EntreMed Inc. (Jun 14, 2001)
• Purchase Agreement [Amendment No. 1] - Bioventure Investments kft and EntreMed Inc. (Jul 13, 2001)
• Purchase Agreement [Amendment No. 2] - Bioventure Investments kft and EntreMed Inc. (Jul 30, 2001)
• Purchase Agreement [Amendment No. 3] - Bioventure Investments kft and EntreMed Inc. (Aug 3, 2001)
• Research Agreement - Children's Hospital and EntreMed Inc. (Oct 1, 1999)
• Research Agreement - EntreMed Inc. and Cytokine Sciences Inc. (Jul 2, 1996)
• Sponsored Research Agreement [Amendment No. 1] - Children's Hospital and EntreMed Inc. (Dec 6, 2000)
• Transition Agreement - EntreMed Inc. and John W. Holaday (Jan 31, 2003)

Enzon Pharmaceuticals Inc.

• Asset Purchase Agreement - Elan Corp. plc, Elan Pharmaceuticals Inc., Elan Operations Inc., Elan Canada Inc. and Enzon Inc. (Oct 1, 2002)

Eon Labs Inc.

• Supply and Manufacturing Agreement - DrugAbuse Sciences Inc. and Eon Labs Manufacturing Inc. (Jul 20, 2000)

EpiCept Corp.

• Employment Agreement - EpiCept Corp. and John V. Talley Jr. (Oct 28, 2004)
• Employment Agreement - EpiCept Corp. and Robert W. Cook (Oct 28, 2004)
• License Agreement - Adolor Corp. and EpiCept Corp. (Jul 23, 2003)
• License Agreement - Endo Pharmaceuticals Inc. and EpiCept Corp. (Dec 18, 2003)
• License Agreement [Amendment No. 1] - Adolor Corp. and EpiCept Corp. (Oct 1, 2004)
• NJ-Englewood Cliffs-270 Sylvan Avenue Lease - Connecticut General Life Insurance Co. and American Pharmed Labs Inc. (Jul 31, 1997)
• Royalty Agreement - EpiCept Corp. and R. Douglas Cassel (Jul 16, 2003)
• Sublicense Agreement - Epitome Pharmaceuticals Ltd. and American Pharmed Labs Inc. (Aug 27, 1999)

Exelixis Inc.

• Collaboration Agreement - Exelixis Inc. and Protein Design Labs Inc. (May 22, 2001)
• Note Purchase Agreement - Exelixis Inc. and Protein Design Labs Inc. (May 22, 2001)

F. Hoffman-La Roche Ltd.

• Agreement - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
• Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
• Agreement [Amendment No. 1] - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Feb 23, 2001)
• Agreement [Amendment No. 2] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd., and Protein Design Labs Inc. (Feb 23, 2001)
• Agreement [Amendment] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Jun 2, 2000)
• Development and License Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 1, 1999)
• Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 5, 2004)
• Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffmann-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 12, 2004)
• Financing Agreement - Trimeris Inc. and Roche Finance Ltd. (Jul 9, 1999)
• Immunity Agreement - Roche Molecular Systems Inc. and ViroLogic Inc. (Aug 4, 1997)
• License Agreement - F. Hoffman-La Roche & Co. Ltd. and Protein Design Labs Inc. (Jan 31, 1989)
• License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and Human Genome Sciences Inc. (Mar 12, 1996)
• License Agreement - Hoffman-La Roche Inc. and Protein Design Labs Inc. (Jan 31, 1989)
• License and Supply Agreement - CombiMatrix Corp. and Roche Diagnostics GmbH (Jul 1, 2001)
• License and Supply Agreement [Amendment No. 1] - CombiMatrix Corp. and Roche Diagnostics GmbH (Nov 30, 2001)
• Nonexclusive Sublicense Agreement - Seragen Inc., Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. (Sep 8, 1999)
• Patent License Agreement - F. Hoffman-La Roche Ltd., Roche Molecular Systems Inc. and Invitrogen Corp. (Jul 1, 1998)
• Research & Development Agreement - Roche Diagnostics GmbH and CombiMatrix Corp. (Jun 18, 2001)
• Research Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 1, 2000)
• Research Agreement [Amendment No. 1] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Nov 13, 2003)
• Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics Inc. (Feb 1, 1998)
• Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics ehf. (Feb 1, 2002)
• Research Collaboration and License Agreement - Syntex (U.S.A.) Inc. and Tularik Inc. (Jul 8, 1997)
• Research Collaboration and License Agreement [Amendment No. 1] - Tularik Inc. and Syntex (U.S.A.) Inc. (Dec 19, 1997)
• Research Collaboration and License Agreement [Amendment No. 2] - Tularik Inc. and Syntex (U.S.A.) LLC (Aug 31, 2000)
• Settlement and Participation Agreement - Tanox Biosystems Inc. and F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., Roche Holding Ltd. and Roche Holdings Inc. (Jul 8, 1996)
• Stock and Warrant Purchase Agreement - Roche Finance Ltd. and deCODE genetics Inc. (Feb 1, 1998)
• Strategic Marketing Alliance Agreement - Roche Diagnostics Corp., Bio-Reference Laboratories Inc. and CareEvolve.com Inc. (Dec 31, 2001)
• Supply and Distributorship Agreement - ACLARA BioSciences Inc. and Roche Diagnostics Corp. (Oct 26, 2001)
• Termination Agreement - Roche Diagnostics Corp. and ACLARA BioSciences Inc. (Oct 10, 2002)
• Worldwide Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design labs Inc. (Oct 1, 2003)

Genentech Inc.

• Collaboration Agreement - Genetech Inc. and TolerRx Inc. (Dec 23, 2002)
• Development Collaboration and License Agreement - Genetech Inc. and CytoTherapeutics Inc. (Nov 22, 1996)
• Discontinuation Agreement - Alkermes Inc. and Genentech Inc. (Apr 4, 1999)
• International License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Jul 25, 2003)
• License Agreement - Alkermes Controlled Therapeutics Inc. and Genentech Inc. (Apr 14, 1999)
• License Agreement - Genentech Inc. and MedImmune Inc. (Jun 4, 1997)
• License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Apr 15, 2002)
• License and Collaboration Agreement [Amendment No. 1] - Tercica Medica Inc. and Genentech Inc. (Jul 25, 2003)
• License and Supply Agreement - VaxGen Inc. and Genentech Inc. (May 1, 1996)
• Manufacture and Supply Agreement - Genentech Inc. and Alkermes Controlled Therapeutics Inc. (Jan 1, 2000)
• Patent Licensing Master Agreement - Protein Design Labs Inc. and Genentech Inc. (Sep 25, 1998)
• Research Agreement - ACLARA BioSciences Inc. and Genentech Inc. (Jul 17, 2002)
• Research Agreement [Amendment No. 1] - ACLARA BioSciences Inc. and Genentech Inc. (Apr 17, 2003)
• Settlement Agreement - Genentech Inc., Genentech International Ltd., Tanox Biosystems Inc. and Ciba-Geigy Ltd. (Jul 8, 1996)
• Settlement and Cross-License Agreement [Amendment No. 1] - Genentech Inc. and Tanox Inc. (Feb 25, 2004)
• Settlement and Cross-Licensing Agreement - Tanox Biosystems Inc. and Genetech Inc. and Genentech International Ltd. (Jul 8, 1996)
• Tripartite Cooperation Agreement - Novartis Pharma AG, Genentech Inc. and Tanox Inc. (Feb 25, 2004)

GenOdyssee SA

• Revolving Line of Credit and Security Agreement - Transgenomic Inc. and GenOdyssee SA (Dec 28, 2001)
• Services Provider Agreement - GenOdyssee SA and Transgenomic Inc. (Dec 28, 2001)
• Term Loan Agreement - Transgenomic Inc. and GenOdyssee SA (Feb 1, 2002)

Genzyme Corp.

• Beta Test Agreement - Sequenom inc. and Genzyme Corp. (Jul 15, 1999)
• Compound Library Screening Agreement - Genzyme Corp. and Cubist Pharmaceuticals Inc. (Feb 24, 1997)
• Development Agreement and United State Distribution Agreement [Amendment] - Genzyme Biosurgery Corp. and Inamed Corp. (Sep 30, 2002)
• Research Agreement - ViaCell Inc. and Genzyme Corp. (Dec 13, 2004)
• United States Distribution Agreement - Genzyme Corp. and Inamed Medical Products Corp. (Nov 29, 2004)

Geron Corp.

• License Agreement [Amendment] - Geron Corp. and Transgenomic Inc. (Jun 2, 2003)

Gilead Sciences Inc.

• Marketing, Distribution and Development Agreement - Gilead Sciences Inc. and Cubist Pharmaceuticals Inc. (Jan 6, 2001)
• NC-Durham-4611 University Drive Sublease - Gilead Sciences Inc. and Trimeris Inc. (Oct 31, 2003)

GlaxoSmithKline

• Asset Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and Healtheon Corp. (Dec 31, 1998)
• Asset Sale Agreement - Diversa Corp. and Glaxo Wellcome SA (Jul 18, 2003)
• Assets Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Dec 31, 1997)
• Collaboration Agreement - G